Biomarin Pharmaceutical Aktie

Kaufen
Verkaufen
51,36 EUR +0,48 EUR +0,94 %
58,06 USD -0,48 USD -0,82 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 9,81 Mrd. EUR

KGV 29,78 Div. Rendite 0,00%

WKN 924801

ISIN US09061G1013

Symbol BMRN


Biomarin Pharmaceutical Aktie Analyse

27.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
22.08.08 Biomarin Pharmaceutical market outperform Rodman & Renshaw, LLC
22.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
29.05.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
28.02.08 Biomarin Pharmaceutical buy Merrill Lynch & Co., Inc.
27.02.08 Biomarin Pharmaceutical market outperform Rodman & Renshaw, LLC
17.12.07 Biomarin Pharmaceutical buy Soleil Securities Group, Inc.
14.12.07 Biomarin Pharmaceutical buy Jefferies & Company Inc.
14.12.07 Biomarin Pharmaceutical market outperform Rodman & Renshaw
05.11.07 Biomarin Pharmaceutical buy Ferris Baker Watts
11.10.07 Biomarin Pharmaceutical outperform Wachovia Sec
28.09.07 Biomarin Pharmaceutical buy Citigroup Corp.
25.09.07 Biomarin Pharmaceutical market outperform Rodman & Renshaw
27.07.07 Biomarin Pharmaceutical buy Ferris Baker Watts
22.03.07 Biomarin Pharmaceutical Der Aktionär
19.02.07 Biomarin Pharmaceutical buy A.G. Edwards & Sons
10.10.06 Biomarin Pharmaceutical Buy Am Tech/ JSA Research
12.06.06 Biomarin Pharmaceutical buy Pacific Growth Equities
17.03.06 Biomarin Pharmaceutical market outperform Rodman & Renshaw
07.02.06 Biomarin Pharmaceutical Market Outperform Rodman & Renshaw
12.05.05 Biomarin Pharmaceutical Market Outperform Rodman & Renshaw
Werbung